In vitro activity of 21 antimicrobials against vancomycin-resistant Staphylococcus aureus (VRSA) and heteroVRSA (hVRSA).

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Antimicrobial Chemotherapy

• Publication date

  2002-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JAC/DKF184PMID 12407140
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital.

  2001cited by this paper
• The development of the BSAC standardized method of disc diffusion testing.

  2001cited by this paper
• Determination of minimum inhibitory concentrations.

  2001cited by this paper
• In Vitro Activities of Daptomycin, Vancomycin, Linezolid, and Quinupristin-Dalfopristin against Staphylococci and Enterococci, Including Vancomycin- Intermediate and -Resistant Strains

  2000cited by this paper
• Effect of different combinations of sparfloxacin, oxacillin, and fosfomycin against methicillin-resistant staphylococci

  1997cited by this paper
• A review of in-vitro antibacterial activity of quinupristin/dalfopristin against methicillin-susceptible and -resistant Staphylococcus aureus.

  1997cited by this paper

• Molecular Epidemiology Clinical Manifestations, Decolonization Strategies, and Treatment Options of Methicillin-Resistant Staphylococcus aureus Infection in Neonates

  2025cites this paper
• Chromosomal and plasmid DNA mediated antibiotic resistance among Staphylococcus aureus obtained from mastitic milk of cattle in Jaipur, Rajasthan

  2025cites this paper
• Skin and soft tissue infections

  2021cites this paper
• Synergistic effects of anti-MRSA herbal extracts combined with antibiotics.

  2020cites this paper
• Emergence of Vancomycin-Resistant Staphylococcus aureus in the Southwest of Iran

  2019cites this paper
• Detection of VanA type vancomycin resistance among MRSA isolates from an emergency hospital in Egypt

  2018cites this paper
• Phenotypic and Molecular Identification of Vancomycin Resistance in Clinical Staphylococcus Aureus Isolates in Osogbo, Nigeria

  2018cites this paper
• Current and future treatment options for community-associated MRSA infection

  2018cites this paper
• Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus

  2015cites this paper
• Two-Photon Excited Fluorescence Detection Technology in Screening for Methicillin-Resistant Staphylococcus aureus

  2013cites this paper
• Agents with Primary Activity Against Gram-Positive Bacteria

  2011cites this paper
• Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

  2011cites this paper
• Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

  2011cites this paper
• Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

  2011cites this paper
• Beta-lactams and Beta-lactamase-inhibitors in current- or potential-clinical practice: A comprehensive update

  2009cites this paper
• Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies

  2009influential citation
• SUSCEPTIBILITY TO VANCOMYCIN IN STAPHYLOCOCCUS AUREUS ISOLATED FROM PATIENTS OF FOUR UNIVERSITY-AFFILIATED HOSPITALS IN TEHRAN

  2008cites this paper
• Synthesis of caprazamycin analogues and their structure--activity relationship for antibacterial activity.

  2008cites this paper
• Emerging Options for Treatment of Invasive, Multidrug‐Resistant Staphylococcus aureus Infections

  2007cites this paper
• Approaches to serious methicillin-resistant Staphylococcus aureus infections with decreased susceptibility to vancomycin: clinical significance and options for management

  2007cites this paper
• Efficacy of Telavancin in the Treatment of Experimental Endocarditis Due to Glycopeptide-Intermediate Staphylococcus aureus

  2007cites this paper
• RESISTANCE OF STAPHYLOCOCCUS AUREUS TO VANCOMYCIN IN ZARQA, JORDAN

  2006cites this paper
• Different antibacterial actions of isoflavones isolated from Erythrina poeppigiana against methicillin‐resistant Staphylococcus aureus

  2006cites this paper
• The first pediatric case of Staphylococcus aureus with heterogenous resistant to vancomycin endocarditis in Thailand.

  2005cites this paper
• VANCOMYCIN RESISTANCE AMONG CLINICAL ISOLATES OF STAPHYLOCOCCUS AUREUS

  2005cites this paper
• Linezolid Pharmacokinetics in Adult Patients with Cystic Fibrosis

  2004influential citation
• 6,7-Dihydroxyflavone Dramatically Intensifies the Susceptibility of Methicillin-Resistant or -Sensitive Staphylococcus aureus to β-Lactams

  2004cites this paper
• Status of combination therapy for refractorymycoses Related review : Status of combination therapy for refractory mycoses

  2003cites this paper
• Linezolid Pharmacokinetics in Adult Patients with Cystic Fibrosis

  2003influential citation
• Frequency of isolation and antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections: a French prospective national survey.

  2003cites this paper